These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 46126)

  • 41. Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments.
    Cullen SE; Nathenson SG
    J Immunol; 1971 Aug; 107(2):563-70. PubMed ID: 4105541
    [No Abstract]   [Full Text] [Related]  

  • 42. Virion polypeptide specificity of immune complexes and antibodies in cats inoculated with feline infectious peritonitis virus.
    Horzinek MC; Ederveen J; Egberink H; Jacobse-Geels HE; Niewold T; Prins J
    Am J Vet Res; 1986 Apr; 47(4):754-61. PubMed ID: 3008607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A glycoprotein specified by spleen focus-forming virus in three cell lines varies on molecular size and peptide composition, but retains both xenotropic and ecotropic MuLV antigenicity.
    Yoshida M; Yoshikura H
    J Gen Virol; 1981 Jan; 52(Pt 1):183-8. PubMed ID: 6267174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Locations and amounts of major structural proteins in bacteriophage lambda.
    Casjens SR; Hendrix RW
    J Mol Biol; 1974 Sep; 88(2):535-45. PubMed ID: 4476800
    [No Abstract]   [Full Text] [Related]  

  • 45. Properties of mouse leukemia viruses. II. Isolation of viral components.
    Schäfer W; Lange J; Fischinger PJ; Frank H; Bolognesi DP; Pister L
    Virology; 1972 Jan; 47(1):210-28. PubMed ID: 4110127
    [No Abstract]   [Full Text] [Related]  

  • 46. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 47. Envelope polypeptides of Friend leukemia virus: purification and structural analysis.
    Schneider J; Falk H; Hunsmann G
    J Virol; 1980 Feb; 33(2):597-605. PubMed ID: 7411688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nature and complexity of the FMR antigenic system.
    Bismuth A; Kremsdorf D; Debré P; Levy JP
    Eur J Immunol; 1979 Aug; 9(8):632-9. PubMed ID: 556553
    [No Abstract]   [Full Text] [Related]  

  • 49. Friend leukemia and mouse endogenous viruses. II. Proteins of Friend leukemia and mouse endogenous C-type particles produced by BALB/c mouse cell cultures.
    Stewart ML; Maizel JV
    Virology; 1975 May; 65(1):67. PubMed ID: 167524
    [No Abstract]   [Full Text] [Related]  

  • 50. Cellular antigen of Friend virus-induced leukemias.
    Steeves RA
    Cancer Res; 1968 Feb; 28(2):338-42. PubMed ID: 5644179
    [No Abstract]   [Full Text] [Related]  

  • 51. Specific afferent interference by antiserum of in vivo immunity.
    Ting C; Herberman RB
    Nature; 1975 Oct; 257(5529):801-2. PubMed ID: 52846
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides.
    Bayer H; Gruber W; Schneider J; Hunsmann G
    EMBO J; 1984 Aug; 3(8):1925-30. PubMed ID: 6479153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera.
    Eckner RJ; Steeves RA
    J Exp Med; 1972 Oct; 136(4):832-50. PubMed ID: 4341440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses.
    Morse HC; Chused TM; Boehm-Truitt M; Mathieson BJ; Sharrow SO; Hartley JW
    J Immunol; 1979 Feb; 122(2):443-54. PubMed ID: 216748
    [No Abstract]   [Full Text] [Related]  

  • 56. Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis.
    Ihle JN; Collins JJ; Lee JC; Fischinger PJ; Pazmino N; Moennig V; Schäfer W; Hanna MG; Bolognesi DP
    Virology; 1976 Nov; 75(1):102-12. PubMed ID: 982843
    [No Abstract]   [Full Text] [Related]  

  • 57. Isolation of proteins by gel filtration in 6M guanidinium chloride: application to RNA tumor viruses.
    Green RW; Bolognesi DP
    Anal Biochem; 1974 Jan; 57(1):108-17. PubMed ID: 4361621
    [No Abstract]   [Full Text] [Related]  

  • 58. Membrane molecules determined by the H-2 associated immune response region: isolation and some properties.
    Cullen SE; David CS; Shreffler DC; Nathenson SG
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):648-52. PubMed ID: 4132532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subviral components of a wild mouse embryo-derived type C oncornavirus.
    Pal BK; Wright M; Officer JE; Gardner MB; Roy-Burman P
    Virology; 1973 Nov; 56(1):189-97. PubMed ID: 4126842
    [No Abstract]   [Full Text] [Related]  

  • 60. The polypeptides of influenza virus. VI. Composition of the neuraminidase.
    Lazdins I; Haslam EA; White DO
    Virology; 1972 Sep; 49(3):758-65. PubMed ID: 5072635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.